Table 2.
(a) Distribution of DRS answers of 31 patients after VTP therapy (n [%]) and (b) patients’ involvement in decision-making (CPS)
![(a) Distribution of DRS answers of 31 patients after VTP therapy (n [%]) and (b) patients’ involvement in decision-making (CPS)](https://karger.silverchair-cdn.com/karger/content_public/journal/uin/106/9/10.1159_000520084/1/000520084_t02.png?Expires=1757414467&Signature=dXDYPBwkSOhWFvK~Z~pfBPlUZ5roxJr5-IOZA1byGOTI2eztrmObzxsK0oomRHjGUvl2rLFa4dn6Hz3MKFVi2hnUanwyvWQhp7V1CKQr-gbJW8B24~ZpwV41i6C-XD0JAEWGJJj48Qens5CMQwRvB2HdWFQSk1NIyLA2HG2FMqc9VMRRTzkbrS656CTfi66Ch6dlhzEDgmHnhErnUkcY~yLFmEdZv0ZCfoeaUU~dMImuC6qwItGQTJ2E1CKHCB6m8VbqnrFI6ZyCpb1fivdfczyVC8EbGzdg82OM61SqwxFrDIKocwKNXJ1GPQcrmQXi~m55-kZsV1YrxysOZfL90w__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
(a) Distribution of DRS answers of 31 patients after VTP therapy (n [%]) and (b) patients’ involvement in decision-making (CPS)
